Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19
Clinical trial NCT04389944 · COMPLETED
Trial details
- NCT number
- NCT04389944
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2020-06-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.